OWN PUBLICATIONS

Scherl M*, Posch U*, Obermoser G, Ammann C, Sepp N, Ulmer H, Dierich MP, Stoiber H, Falkensammer B.

* MS and UP contributed equally to the work

Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease.

Lupus. 2006;15:865-872.

Read online

Mueller T, Posch UC, Lindner HH.

Separation of phenylthiohydantoin amino acids by capillary electrochromatography. Electrophoresis.

2004 Feb;25:578-585.

Read online

EXAMPLES OF MANUSCRIPTS / EDITORIAL SUPPORT

Kähler C., Derezinski T., Bocian-Sobkowska J., Keckeis A., Zacke G.

Spicae aetheroleum in uncomplicated acute bronchitis: a double-blind, randomised clinical trial.

Wien Med Wochenschr (2017). https://doi.org/10.1007/s10354-017-0612-0

Read online (Refer to “Acknowledgement section”)

Trimmel H., Majdan M., Wodak A., Herzer G., Csomor D., Brazinova A.

CITICOLINE IN SEVERE TRAUMATIC BRAIN INJURY: INDICATIONS FOR IMPROVED OUTCOME : A RETROSPECTIVE MATCHED PAIR ANALYSIS FROM 14 AUSTRIAN TRAUMA CENTERS.

Wien Klin Wochenschr. 2017 Jul 27. doi: 10.1007/s00508-017-1240-9. (epub ahead of print)

Read online (Refer to “Acknowledgement section”)

Willenbacher E., Willenbacher W., Gunsilius E.

Sustained response to single agent therapy with continuous lenalidomide in a pre-treated high-risk multiple myeloma patient.

Memo – Magazine of European Medical Oncology 2012; 5:27-29.

Read online (Refer to “Acknowledgement section”)

Skrabs C, Sillaber C, Schiefer AI, Simonitsch-Klupp I, Staudinger T, Putman M, Rabitsch W, Jaeger U

Lenalidomide induced response in a patient with follicular lymphoma of the skin and an anti-rituximab-antibody.

Memo – Magazine of European Medical Oncology 2013;6:123-126.

Read online (Refer to “Acknowledgement section”)

EXAMPLES OF SCIENTIFIC POSTERS

Gapp Guenther,

PRACTICAL APPLICATIONS AND BENEFITS OF STERILE PRODUCT COMPLIANCE RISK ASSESSMENTS AND CASE STUDIES.

2017 PDA Annual Meeting, April 3-5, Anaheim, CA

günther gapp pda poster 2017 Click to download poster as PDF

Gapp Guenther,

ASEPTIC PROCESSING HOT TOP FROM THE VIEW OF A SENIOR QA MICROBIOLOGIST AND PRACTICAL EXPERIENCES IN USAGE OF STERILE RISK ASSESSMENT TOOLS.

2015 PDA Annual Meeting, March 16-18, Las Vegas, Nevada

guenther gapp ulrike posch Click to download poster as PDF

I HAVE EXPERIENCE IN THE FOLLOWING SCIENTIFIC AND MEDICAL FIELDS

  • Acute bronchitis
  • Antibody-mediated (chemo)therapies
  • EHEC (Enterohaemorrhagic E. coli)
  • ESBL (Extended-Spectrum Beta-Lactamases)
  • Haematology
    • Acute myeloid leukemia (AML)
    • Follicular lymphoma (FL)
    • Multiple myeloma (MM)
    • Myelodysplastic syndrome (MDS)
  • HIV
  • Immune thrombocytopenia (ITP)
  • Immunomodulatory agents (IMIDs)
  • Immuno-oncology (Talimogene Laherparepvec (T-VEC), BiTE antibody)
  • Nephrology
  • Emergency contraception
  • Oncology
    • Breast cancer (mBC)
    • Colorectal cancer (mCRC)
    • Non-small cell lung cancer (NSCLC)
    • Pancreatic cancer (PDAC)
  • Osteoporosis
  • Secondary hyperparathyroidism
  • Sterile production in the pharmaceutical industry
  • Systemic lupus erythematosus (SLE)
  • Traumatic brain injury (TBI)